Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Change in Account Payables (2023 - 2025)

BrightSpring Health Services' Change in Account Payables history spans 3 years, with the latest figure at $221.3 million for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 49.91% year-over-year to $221.3 million; the TTM value through Dec 2025 reached $264.2 million, down 12.87%, while the annual FY2025 figure was $264.2 million, 12.87% down from the prior year.
  • Change in Account Payables reached $221.3 million in Q4 2025 per BTSG's latest filing, up from -$10.4 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $221.3 million in Q4 2025 to a low of -$67.0 million in Q1 2023.
  • Average Change in Account Payables over 3 years is $56.1 million, with a median of $26.5 million recorded in 2023.
  • The largest YoY upside for Change in Account Payables was 443.24% in 2025 against a maximum downside of 349.35% in 2025.
  • A 3-year view of Change in Account Payables shows it stood at $164.0 million in 2023, then dropped by 9.95% to $147.6 million in 2024, then skyrocketed by 49.91% to $221.3 million in 2025.
  • Per Business Quant, the three most recent readings for BTSG's Change in Account Payables are $221.3 million (Q4 2025), -$10.4 million (Q3 2025), and $107.1 million (Q2 2025).